Thiotepa and Treosulfan Based Myeloablative Conditioning in T-cell Replete Haploidentical Hematopoietic Stem Cell Transplant Among Patients with Haematological Disorders.

Key Points

• Myeloablative conditioning significantly enhances outcomes in patients with hematological disorders.
• Key evidence indicates a reduction in relapse rates and improved overall survival post-transplant.
• Assessment of hematopoietic stem cell transplant utilizing thiotepa and treosulfan shows promising results.
• The findings highlight the need for further research into optimizing conditioning regimens for effective therapy.